Cancer-killing virus injected into human for the first time in new clinical trial

Cancer-killing virus injected into human for the first time in new clinical trial

A recent Phase 1 clinical trial has administered a dose of an experimental anticancer drug called CF33-hNIS, or Vaxinia, to the study’s first participant. This novel therapy involves using an oncolytic virus, a type of virus that can infect and kill cancer cells without harming healthy tissue. Vaxinia, a genetically modified smallpox virus, has been previously shown to be effective against a broad range of cancers in laboratory and animal models. This clinical trial conducted by City of Hope, a cancer research and treatment institute in the United States, in collaboration with Imugene, a biotech company in Australia, will test the novel oncolytic virus in cancer patients with advanced solid tumors.

FULL ARTICLE LINK BELLOW

* * * * * * * *

“This publication is an exact copy of author’s original, it is intended to share information regarding COVID-19.  The information on this publication does not necessarily reflect the opinion of Premiere Scientific LLC or the opinion of any of its employees.”

* * * * * * * *

INFO SOURCED FROM MEDICALNEWSTODAY.COM

Written by Deep Shukla on June 2, 2022

IMAGE: Sebastian Condrea/Getty Images

For full article click HERE.

Back to blog